{"id":"ccp","safety":{"commonSideEffects":[{"rate":null,"effect":"Transfusion-related acute lung injury (TRALI)"},{"rate":null,"effect":"Allergic reactions"},{"rate":null,"effect":"Volume overload"},{"rate":null,"effect":"Transfusion-transmitted infection"}]},"_chembl":null,"_dailymed":{"setId":"a4857d8a-b915-3748-e053-2a95a90ab55c","title":"VK (CYPRESS OIL, EUCALYPTUS OIL, CORAL CALCIUM (CT-CCP40)) LIQUID [CALTECBIO CO., LTD]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Convalescent plasma contains polyclonal antibodies against SARS-CoV-2 that were generated in recovered patients. When transfused into acutely infected patients, these antibodies provide immediate passive immunity to neutralize circulating virus and enhance viral clearance. The mechanism relies on antibody-mediated viral neutralization and complement activation rather than stimulating the recipient's own immune response.","oneSentence":"CCP is a convalescent plasma product that provides passive immunotherapy through antibodies from recovered COVID-19 patients to treat active SARS-CoV-2 infection.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:49:48.222Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 (acute infection, particularly in hospitalized or immunocompromised patients)"}]},"trialDetails":[{"nctId":"NCT06010160","phase":"NA","title":"Game Changers for Cervical Cancer Prevention","status":"ACTIVE_NOT_RECRUITING","sponsor":"RAND","startDate":"2024-08-19","conditions":"Cervical Cancer","enrollment":1400},{"nctId":"NCT07483463","phase":"","title":"Risk of Hydroceles Following Pyeloplasty","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"1992-07-01","conditions":"Hydrocele, Hydrocelectomy, Pyeloplasty","enrollment":15000},{"nctId":"NCT04989205","phase":"","title":"Community Based Cannabis Cessation Program","status":"COMPLETED","sponsor":"Sorlandet Hospital HF","startDate":"2013-06-02","conditions":"Cannabis Use","enrollment":102},{"nctId":"NCT07306000","phase":"NA","title":"Pilot Study: Effects of CCP Intervention on NICU Environment and Preterm Infants Development","status":"RECRUITING","sponsor":"Turku University Hospital","startDate":"2025-12-22","conditions":"Preterm Infant Development, Preterm Infant Health","enrollment":100},{"nctId":"NCT01929005","phase":"NA","title":"Comprehensive Care Physician: Integrated Inpatient and Outpatient Care for Patients at High Risk of Hospitalization","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2012-11","conditions":"Medicare Patients, High Risk of Hospitalizations","enrollment":2008},{"nctId":"NCT04497779","phase":"","title":"Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2020-07-13","conditions":"Asymptomatic COVID-19 Infection Laboratory-Confirmed, Symptomatic COVID-19 Infection Laboratory-Confirmed","enrollment":95},{"nctId":"NCT07245212","phase":"NA","title":"Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosis (FEP)","status":"NOT_YET_RECRUITING","sponsor":"King's College London","startDate":"2025-12-01","conditions":"Psychosis, Cannabis Use Disorder, First Episode Psychosis (FEP)","enrollment":80},{"nctId":"NCT06588400","phase":"NA","title":"AOSEPT (CLEAR CARE) PLUS Study","status":"WITHDRAWN","sponsor":"Alcon Research","startDate":"2025-10","conditions":"Contact Lens Care","enrollment":""},{"nctId":"NCT07129837","phase":"","title":"Serum Anti-PCOLCE as Novel Diagnostic Biomarker in Rheumatoid Arthritis With Emphasis on Seronegative Patients.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05","conditions":"Rheumatoid Arthritis","enrollment":62},{"nctId":"NCT04489693","phase":"NA","title":"Comprehensive Care Community and Culture Study","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2019-03-06","conditions":"Comprehensive Care, Quality of Care, Medicare","enrollment":3000},{"nctId":"NCT02012764","phase":"","title":"The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ?","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Leeds","startDate":"2007-01","conditions":"Inflammatory Arthritis, Rheumatoid Arthritis","enrollment":4000},{"nctId":"NCT04261023","phase":"PHASE2","title":"Abatacept in Individuals Who aRe Considered At Risk of Developing Inflammatory Arthritis","status":"TERMINATED","sponsor":"University of Leeds","startDate":"2020-02-24","conditions":"Inflammatory Arthritis","enrollment":6},{"nctId":"NCT00512239","phase":"","title":"Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset","status":"RECRUITING","sponsor":"Gilles Boire","startDate":"1998-07","conditions":"Rheumatoid Arthritis, Inflammatory Arthritis","enrollment":1000},{"nctId":"NCT04603105","phase":"","title":"CCP Cancer UK Companion Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Clatterbridge Cancer Centre NHS Foundation Trust","startDate":"2021-02-28","conditions":"Cancer, Covid19","enrollment":9000},{"nctId":"NCT06792292","phase":"NA","title":"Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital","status":"NOT_YET_RECRUITING","sponsor":"Chirec","startDate":"2025-02-01","conditions":"Artificial Intelligence, Colonic Adenoma, Colonic Neoplasms","enrollment":765},{"nctId":"NCT06513507","phase":"NA","title":"A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Raphael Pharma","startDate":"2024-06-03","conditions":"Rheumatoid Arthritis, Inflammatory Disease","enrollment":12},{"nctId":"NCT05271929","phase":"PHASE3","title":"Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19","status":"TERMINATED","sponsor":"Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen","startDate":"2022-04-01","conditions":"COVID-19","enrollment":120},{"nctId":"NCT06594822","phase":"PHASE3","title":"Effectiveness of Probiotics in Patients of Mild to Moderate Rheumatoid Arthritis","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2023-08-24","conditions":"Rheumatoid Arthritis","enrollment":88},{"nctId":"NCT06540573","phase":"","title":"The Relationship Between Serum Chemokine Ligand 21 (CCL-21) Level and Disease Activity","status":"NOT_YET_RECRUITING","sponsor":"Gaziosmanpasa Research and Education Hospital","startDate":"2024-08-12","conditions":"Rheumatoid Arthritis, Osteoarthritis","enrollment":60},{"nctId":"NCT06104579","phase":"","title":"Concordance Between Monitoring Systems for Organ/Space Surgical Site Infections in Rectal Surgery","status":"COMPLETED","sponsor":"Hospital de Granollers","startDate":"2011-01-01","conditions":"Rectal Cancer, Organ-Space Surgical Site Infection","enrollment":11367},{"nctId":"NCT04412486","phase":"EARLY_PHASE1","title":"COVID-19 Convalescent Plasma (CCP) Transfusion","status":"COMPLETED","sponsor":"Gailen D. Marshall Jr., MD PhD","startDate":"2020-06-01","conditions":"COVID-19","enrollment":86},{"nctId":"NCT04744402","phase":"PHASE2","title":"Phase 2 Clinical Trial of CartiLife® in the United States","status":"UNKNOWN","sponsor":"Biosolution Co., Ltd.","startDate":"2020-10-28","conditions":"Articular Cartilage Defect, Articular Cartilage Degeneration","enrollment":25},{"nctId":"NCT05938244","phase":"","title":"Cardiac and Pulmonary Assessment in Egyptian Patients With Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-08","conditions":"Rheumatoid Arthritis","enrollment":34},{"nctId":"NCT05904067","phase":"NA","title":"A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID-19 in Adult Recipients Following Hematopoietic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-06-10","conditions":"COVID-19, Hematopoietic Stem Cell Transplantation","enrollment":72},{"nctId":"NCT03821090","phase":"","title":"Rheumatoid Arthritis Disease Activity and Sub Clinical Atherosclerosis","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-04-15","conditions":"Rheumatoid Arthritis","enrollment":160},{"nctId":"NCT04003220","phase":"","title":"Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker","status":"UNKNOWN","sponsor":"University Hospital, Bordeaux","startDate":"2020-09-07","conditions":"Thrombocytopenia, Purpura, Thrombocytopenic, Myelodysplastic Syndromes","enrollment":80},{"nctId":"NCT05584878","phase":"NA","title":"Remineralizing Potential of Biomimetic Scaffolds on Enamel White Spot Lesions","status":"UNKNOWN","sponsor":"Hams Hamed Abdelrahman","startDate":"2023-01-01","conditions":"White Spot Lesion","enrollment":63},{"nctId":"NCT04421404","phase":"PHASE2","title":"Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients","status":"COMPLETED","sponsor":"Priscilla Hsue, MD","startDate":"2020-06-09","conditions":"COVID-19, Sars-CoV2","enrollment":34},{"nctId":"NCT04539275","phase":"PHASE3","title":"VA CoronavirUs Research and Efficacy Studies-1","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2020-11-16","conditions":"COVID-19","enrollment":75},{"nctId":"NCT03290508","phase":"","title":"Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer","status":"TERMINATED","sponsor":"Myriad Genetic Laboratories, Inc.","startDate":"2017-09-14","conditions":"Prostate Cancer","enrollment":524},{"nctId":"NCT03152448","phase":"","title":"Prospective Prolaris Value and Efficacy","status":"TERMINATED","sponsor":"Myriad Genetic Laboratories, Inc.","startDate":"2015-09-01","conditions":"Prostate Cancer","enrollment":1511},{"nctId":"NCT04438057","phase":"PHASE2","title":"Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19","status":"COMPLETED","sponsor":"Metro Infectious Disease Consultants","startDate":"2020-08-12","conditions":"COVID-19","enrollment":103},{"nctId":"NCT03267147","phase":"","title":"PREVALENCE OF Anti-CCP POSITIVITY AND SUBCLINICAL SIGNS OF INFLAMMATION IN PATIENTS WITH NEW ONSET OF NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS","status":"COMPLETED","sponsor":"Fraunhofer Institute for Translational Medicine and Pharmacology ITMP","startDate":"2017-04-27","conditions":"Rheumatoid Arthritis","enrollment":986},{"nctId":"NCT04173975","phase":"NA","title":"Validation of the Efficacy and Usability of the BELK Orthosis Knee Module in a Neurological Setting (BELK@CCP)","status":"WITHDRAWN","sponsor":"Casa di Cura Privata del Policlinico SpA","startDate":"2021-01-01","conditions":"Knee Instability, Neuromuscular Diseases, Central Nervous System Diseases","enrollment":""},{"nctId":"NCT02911675","phase":"","title":"Assessing the Accuracy and the Impact of Standard-practice Ventricular Drainage on Intracranial Pressure Measurements Following Traumatic Brain Injury","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2018-12-01","conditions":"Traumatic Brain Injury","enrollment":""},{"nctId":"NCT04502472","phase":"PHASE2, PHASE3","title":"Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma","status":"TERMINATED","sponsor":"Inova Health Care Services","startDate":"2020-06-06","conditions":"Covid-19","enrollment":109},{"nctId":"NCT04524507","phase":"PHASE2","title":"Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-08-27","conditions":"COVID-19","enrollment":56},{"nctId":"NCT04428502","phase":"","title":"Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2020-07-05","conditions":"Psoriatic Arthritis","enrollment":127},{"nctId":"NCT04428424","phase":"","title":"Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients","status":"COMPLETED","sponsor":"Pfizer","startDate":"2020-07-05","conditions":"Arthritis, Rheumatoid","enrollment":1493},{"nctId":"NCT04361253","phase":"PHASE3","title":"Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2020-04-30","conditions":"COVID, Infectious Disease","enrollment":45},{"nctId":"NCT04945525","phase":"NA","title":"Comparing a Patient Self-Assessment Software to Treatment as Usual in Opioid Prescriber and Patient Opioid Outcomes","status":"UNKNOWN","sponsor":"Sure Med Compliance","startDate":"2021-05-26","conditions":"Opioid-use Disorder, Opioid Misuse, Opioid Use","enrollment":1840},{"nctId":"NCT04374526","phase":"PHASE2, PHASE3","title":"Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2020-05-27","conditions":"Coronavirus Disease 2019 )COVID-19)","enrollment":29},{"nctId":"NCT04855279","phase":"NA","title":"Prevention of Bleaching Induced Sensitivity","status":"COMPLETED","sponsor":"Medipol University","startDate":"2019-01-07","conditions":"Tooth Bleaching, Tooth Sensitivity","enrollment":64},{"nctId":"NCT04542941","phase":"NA","title":"Assessment of Safety and Efficacy of CCP","status":"COMPLETED","sponsor":"Makerere University","startDate":"2020-06-16","conditions":"Covid19","enrollment":136},{"nctId":"NCT03429426","phase":"","title":"Progression of Bone Erosions in Rheumatoid Arthritis Assessed by HR-pQCT and Conventional X-ray","status":"ENROLLING_BY_INVITATION","sponsor":"Aarhus University Hospital","startDate":"2018-02-15","conditions":"Arthritis, Rheumatoid","enrollment":625},{"nctId":"NCT04634422","phase":"NA","title":"Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure","status":"UNKNOWN","sponsor":"Wladimir Szpirt","startDate":"2020-11-16","conditions":"Respiratory Failure, Renal Failure, Acute","enrollment":220},{"nctId":"NCT04516811","phase":"PHASE3","title":"Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19","status":"UNKNOWN","sponsor":"South African National Blood Service","startDate":"2020-09-21","conditions":"COVID-19, SARS-CoV-2 Infection, Severe Acute Respiratory Syndrome Coronavirus 2","enrollment":600},{"nctId":"NCT04474340","phase":"PHASE1","title":"COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients","status":"UNKNOWN","sponsor":"Ministry of Health, Kuwait","startDate":"2020-05-21","conditions":"Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia, Pneumonia, Viral","enrollment":300},{"nctId":"NCT02956395","phase":"NA","title":"Implementation of Community-based Collaborative Management of Complex Chronic Patients","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2018-02-01","conditions":"Chronic Disease, Integrated Care, Telemedicine","enrollment":3000},{"nctId":"NCT03194204","phase":"NA","title":"Re-evaluation of Some Old Rheumatoid Arthritis Therapy: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-10-01","conditions":"Rheumatoid Arthritis","enrollment":160},{"nctId":"NCT04374227","phase":"NA","title":"The Effect of Osteopathic Manipulative Treatment (OMT) on Proprioception in Adults","status":"COMPLETED","sponsor":"Des Moines University","startDate":"2019-10-16","conditions":"Osteopathy in Diseases Classified Elsewhere","enrollment":34},{"nctId":"NCT03225950","phase":"","title":"Interaction Between Immune Cells and Bacteria Associated With Periodontitis","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2017-02-01","conditions":"Periodontal Diseases, Periodontitis, Aggressive Periodontitis","enrollment":90},{"nctId":"NCT03963791","phase":"NA","title":"Remineralization Effect of Eggshell Powder on Post-orthodontic White Spot Lesions Compared to CPP-ACP","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-10-05","conditions":"Dental Caries","enrollment":24},{"nctId":"NCT03213028","phase":"NA","title":"Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2017-08-18","conditions":"Family Planning","enrollment":248},{"nctId":"NCT03026257","phase":"NA","title":"Clinical Assessment of a HYDRAGLYDE® Regimen","status":"COMPLETED","sponsor":"Alcon, a Novartis Company","startDate":"2017-02-13","conditions":"Refractive Errors, Myopia, Hypermetropia","enrollment":323},{"nctId":"NCT03624179","phase":"","title":"Study of Some Risk Factors for Developing RA","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-08-15","conditions":"Rheumatoid Arthritis","enrollment":60},{"nctId":"NCT02046005","phase":"NA","title":"Personalized Risk Estimator for Rheumatoid Arthritis Family Study","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2014-01","conditions":"First Degree Relatives of Rheumatoid Arthritis Patients","enrollment":238},{"nctId":"NCT02965833","phase":"NA","title":"CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers","status":"COMPLETED","sponsor":"Alcon, a Novartis Company","startDate":"2016-12-13","conditions":"Presbyopia","enrollment":126},{"nctId":"NCT03224377","phase":"","title":"Diagnostic Utility of Anti MCV Antibodies,Anti CCPantibodies and RF in RA","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-10-09","conditions":"Rheumatoid Arthritis","enrollment":80},{"nctId":"NCT01526876","phase":"PHASE4","title":"The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2011-11","conditions":"Hypertension","enrollment":""},{"nctId":"NCT03091036","phase":"NA","title":"Impact of a Health Intervention on Some Indicators in the Care of Chronic Complex Patient (CCP).","status":"COMPLETED","sponsor":"María José del Olmo Rubio","startDate":"2015-07","conditions":"Preventive Care","enrollment":28},{"nctId":"NCT01309282","phase":"","title":"An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2010-07","conditions":"Rheumatoid Arthritis","enrollment":9},{"nctId":"NCT02735330","phase":"NA","title":"Intraoperative Coeliac Plexus Alcohol Neurolysis Along With Frey's Procedure for a Better Pain Relief","status":"UNKNOWN","sponsor":"Madras Medical College","startDate":"2013-01","conditions":"Chronic Calcific Pancreatitis","enrollment":136},{"nctId":"NCT02147743","phase":"NA","title":"Preventing Adolescents From Entering the Juvenile Justice System","status":"COMPLETED","sponsor":"University of Miami","startDate":"2009-05","conditions":"Substance Use, Delinquency","enrollment":120},{"nctId":"NCT01078597","phase":"","title":"A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RA","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2010-09","conditions":"Rheumatoid Arthritis","enrollment":35},{"nctId":"NCT00523692","phase":"PHASE4","title":"Remission Induction in Very Early Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"University Hospital Birmingham","startDate":"2007-09","conditions":"Rheumatoid Arthritis","enrollment":20}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"HYPERMAGNESAEMIA"},{"count":1,"reaction":"ABDOMINAL DISCOMFORT"},{"count":1,"reaction":"ALANINE AMINOTRANSFERASE INCREASED"},{"count":1,"reaction":"ASPARTATE AMINOTRANSFERASE INCREASED"},{"count":1,"reaction":"DIARRHOEA"},{"count":1,"reaction":"EPSTEIN-BARR VIRUS ANTIBODY POSITIVE"},{"count":1,"reaction":"LIVER FUNCTION TEST ABNORMAL"},{"count":1,"reaction":"MUSCLE SPASMS"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["convalescent plasma"],"phase":"marketed","status":"active","brandName":"CCP","genericName":"CCP","companyName":"Metro Infectious Disease Consultants","companyId":"metro-infectious-disease-consultants","modality":"Biologic","firstApprovalDate":"","aiSummary":"CCP is a convalescent plasma product that provides passive immunotherapy through antibodies from recovered COVID-19 patients to treat active SARS-CoV-2 infection. Used for COVID-19 (acute infection, particularly in hospitalized or immunocompromised patients).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}